Crescent Capital BDC, Inc. (CCAP) stock intrinsic value fair value estimate & owner earnings analysis

Crescent Capital BDC is a business development company that lends to private, middle-market companies, mostly through senior secured first-lien floating-rate term loans, revolvers and delayed-draw loans, and is externally managed by Crescent Capital. At June 30, 2026 it held $1.57 billion of investments at fair value. At the end of 2025, 87.3% of the portfolio by fair value was in the United States, 5.2% in the United Kingdom and 2.0% in Australia, with the rest in other countries. Shareholders receive the interest those loans pay, less the company's own borrowing costs and the manager's fees, and most of it is paid out as dividends. How we measure earnings. A lender's operating cash flow is dominated by loans made and repaid, so we use net investment income per share (income after interest, management and incentive fees and taxes) and deduct credit losses separately as the recurring cost of keeping the loan book whole. Net investment income per share was $1.65 (2018), $1.83 (2019), $1.80 (2020), $1.67 (2021), $1.93 (2022), $2.30 (2023), $2.40 (2024) and $1.81 (2025), and $0.78 in the first half of 2026 ($0.42 in the first quarter and $0.36 in the second). The 2023-2024 peak depended on short-term rates that have since fallen, so we do not use it. Net realized and unrealized gains or losses per share were -$0.89 (2018), -$0.14 (2019), +$0.18 (2020), +$1.27 (2021), -$1.43 (2022), +$0.03 (2023), -$0.41 (2024), -$0.88 (2025) and -$1.29 in the first half of 2026 alone. Net asset value per share fell from $19.98 at the end of 2024 to $19.10 at the end of 2025 and $17.82 at June 30, 2026. The company's record covers no recession-sized credit cycle, so the downside has to be sized from the history of other BDCs. What changed in 2026. From April 1, 2026 the manager cut its base fee from 1.25% to 1.00% of assets and its incentive fee from 17.5% to 15.0%. The board reduced the regular quarterly dividend from $0.42 to $0.34 starting with the second quarter and declared $0.09 of special dividends payable in three $0.03 instalments. The 2026 note maturities have been dealt with: the $135 million of 4.00% notes due February 2026 were refinanced with $67.5 million of notes due February 2029 and $67.5 million due February 2031; the $111.6 million of 5.00% notes were repaid on May 22 alongside a new $50 million issue at 5.97% due May 2029; and the $50 million of 7.54% notes due July 2026 were prepaid on June 29. A smaller tranche of notes due 2028 remains outstanding. Starting level and growth check. The second quarter of 2026 is the first with the lower fees; its $13.1 million of net investment income on 36.85 million shares is $1.42 a share annualized. On September 16, 2026 the Federal Reserve raised its target rate by a quarter point, and the company's 2025 annual report estimates that each quarter-point rise adds about $2.3 million of net interest income a year, roughly $0.05 a share after incentive fees. Our base case starts from $1.47. Net investment income per share fell 24.6% in 2025, and earnings after credit losses fell 53% ($1.99 to $0.93). Our base case's first year, $0.59 after losses, is a further 37% decline, and no growth is credited after that. The portfolio was flat in the first half of 2026 ($1.569 billion to $1.571 billion). The company's past growth came from acquiring other lenders, Alcentra Capital and First Eagle Alternative Capital BDC (March 2023, paid partly with 6.17 million new shares), and neither a new acquisition nor new capital is in hand. How the debt is treated. Borrowing is the raw material of a lender, so we value income after interest and do not subtract the debt a second time. At June 30, 2026 the company owed $935 million of principal ($923 million carrying value) against $656 million of shareholders' equity, $15.6 million of cash and $1.57 billion of investments, about 1.4 times debt to equity. Asset coverage was about 170% against the 150% legal minimum for BDCs: equity can absorb about $189 million of losses, $5.12 a share, before the company falls below that floor, at which point it cannot pay dividends or borrow more and must shrink. BDCs were limited to 1-to-1 debt to equity in 2008, so the company carries more leverage into a downturn than the lenders whose record we use below. Base case, $15.62 per share. Income of $1.47 a share. Credit losses of $0.88 a share in each of the next two years, the average since 2022 and below the first-half 2026 pace, then $0.49 a year, the average from 2021 to mid-2026. That leaves $0.59 a year of earnings after losses for two years, then $0.98 a year. The loan book is continually re-lent, so this earning power persists as long as losses are replaced. The base sits below the $17.82 net asset value because income after losses is a low return on that capital. Bear case, $6.27 per share. A 2008-2009-style credit cycle sized from the sector's own record. Ares Capital, one of the largest BDCs and less leveraged than Crescent is today, lost $266 million on investments in 2008, 14.6% of its $1.83 billion of assets at the start of the year; its net asset value per share fell from $15.47 to $11.27, and it raised equity in 2008 through a rights offering at about $11.93 a share net, below its $15.47 net asset value. Apollo Investment's net asset value fell from $19.09 in mid-2007 to $9.82 in March 2009 and it halved its quarterly dividend; Allied Capital's fell from $17.54 at the end of 2007 to $6.66 at the end of 2009. Applying Ares Capital's 14.6% to Crescent's $1.57 billion book gives losses of about $229 million, $6.22 a share, over two years. That exceeds the $189 million coverage cushion, so the company must shed loans to repay debt; restoring coverage to about 170% means disposing of roughly $325 million of loans, and at a 10% discount that adds about $0.88 a share of losses. As at Ares Capital in 2009, about a quarter of the markdowns, $1.62 a share, recovers, spread over years three and four. Net investment income falls to $1.30 and then $1.00 as loans stop paying and the book shrinks, is about $0.85 in years three and four, and settles near $0.98 once the smaller book is rebuilt, with ongoing losses of about $0.34. Earnings after losses are -$1.81, -$2.99, $1.34 and $1.34 a share, then $0.64 a year. Net asset value falls about 40% at the low and ends near $12.34. Investment income covers interest in every year: the lenders are paid and shareholders absorb the losses. Raising equity at a deep discount instead of shrinking would cost shareholders a similar amount through dilution. The bear value is well below net asset value because about a third of that capital is lost in this case. Bull case, $23.33 per share. Loans now not paying interest return to paying, and income returns to the $1.68-a-share annual pace of the first quarter of 2026; losses run at $0.28 a share, the 2018-2025 average. That leaves $1.40 a year. Testing the case. We tested whether the 2026 losses were a single markdown: they were spread across both quarters ($0.84 a share in the first and $0.45 in the second), so the base case charges the current-cycle rate for two more years rather than the long-run average. We tested whether the first-lien focus justifies a milder cycle than Ares Capital's: the first half of 2026, without a recession, already cost nearly 7% of net asset value ($1.29 on $19.10), so we did not reduce the loss rate for loan seniority. Several loans pay part of their interest in kind, added to the loan balance rather than paid in cash, which would turn into losses if those borrowers fail. Margin-of-safety price, $8.00. We are reasonably sure of the income, which has an eight-year record and now reflects lower fees, and much less sure of the losses, which have run well above the long-run average since 2022 and were heavier still in 2026. The worst plausible outcome is a recession deeper than the one in the bear case, like the ones Apollo Investment and Allied Capital went through; at Crescent's leverage a loss of that depth would force both large loan disposals and new equity at depressed prices, and the shares could be worth well under the bear value. The structure limits but does not remove that risk: the loans are floating-rate and senior, the borrowings are unsecured notes and revolving facilities with no note maturities left in 2026, and the 150% coverage rule forces shrinkage before the lenders are at risk, which means the shareholders bear a deep cycle. If we are wrong about the two things we are most likely to be wrong about, with income settling at $1.30 instead of $1.47 and losses staying at $0.60 a year, earnings after losses of $0.70 a year would make the shares worth about $11.67. The price assumes a three-to-five-year holding period, during which the business currently pays $1.36 a year in regular dividends. From $8.00, the base case implies about 28% a year over five years; the path just described implies about 21% a year; and the bear case, with the dividend cut and then suspended for a year, implies about 15% a year over four years. Because a cycle as deep as Apollo Investment's or Allied Capital's would take the outcome below the bear case, the margin-of-safety price sits much nearer the bear value than the base. Since our previous estimate, the first-half 2026 losses and the dividend reduction make the near-term path heavier, while the fee cut, the completed refinancing of the 2026 notes and the September rate rise partly offset that. The earlier bear case was built on a different basis and is not comparable. What would make this wrong: rate cuts would lower income in every case, and a credit cycle deeper than Ares Capital's 2008 would push value below the bear case. The count of loans not paying interest at June 30, 2026 could not be confirmed from the filings available to us.